<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39337536</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>18</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle><i>Staphylococcus aureus</i> Co-Infection in COVID-19 Patients: Virulence Genes and Their Influence on Respiratory Epithelial Cells in Light of Risk of Severe Secondary Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10050</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms251810050</ELocationID><Abstract><AbstractText>Pandemics from viral respiratory tract infections in the 20th and early 21st centuries were associated with high mortality, which was not always caused by a primary viral infection. It has been observed that severe course of infection, complications and mortality were often the result of co-infection with other pathogens, especially <i>Staphylococcus aureus</i>. During the COVID-19 pandemic, it was also noticed that patients infected with <i>S. aureus</i> had a significantly higher mortality rate (61.7%) compared to patients infected with SARS-CoV-2 alone. Our previous studies have shown that <i>S. aureus</i> strains isolated from patients with COVID-19 had a different protein profile than the strains in non-COVID-19 patients. Therefore, this study aims to analyze <i>S. aureus</i> strains isolated from COVID-19 patients in terms of their pathogenicity by analyzing their virulence genes, adhesion, cytotoxicity and penetration to the human pulmonary epithelial cell line A549. We have observed that half of the tested <i>S. aureus</i> strains isolated from patients with COVID-19 had a necrotizing effect on the A549 cells. The strains also showed greater variability in terms of their adhesion to the human cells than their non-COVID-19 counterparts.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Piechowicz</LastName><ForeName>Lidia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9222-7330</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, Medical University of Gdansk, Debowa 25, 80-204 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosznik-Kwaśnicka</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5023-1531</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, Medical University of Gdansk, Debowa 25, 80-204 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarzembowski</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1622-1807</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, Medical University of Gdansk, Debowa 25, 80-204 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daca</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1485-3090</Identifier><AffiliationInfo><Affiliation>Department of Physiopathology, Medical University of Gdansk, Debinki 7, 80-211 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Necel</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9051-4077</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, Medical University of Gdansk, Debowa 25, 80-204 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonawenturczak</LastName><ForeName>Ada</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werbowy</LastName><ForeName>Olesia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stasiłojć</LastName><ForeName>Małgorzata</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4221-5803</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology and Immunology, Intercollegiate Faculty of Biotechnology of University of Gdansk and Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pałubicka</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7573-4488</Identifier><AffiliationInfo><Affiliation>Specialist Hospital in Koscierzyna Sp. z o.o., Department of Laboratory and Microbiological Diagnostics, Koscierzyna, Alojzego Piechowskiego 36, 83-400 Koscierzyna, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>71-01415/004602/61/289/2022 task no. 0003384</GrantID><Agency>Medical University of Gdańsk,</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013211" MajorTopicYN="Y">Staphylococcus aureus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013203" MajorTopicYN="Y">Staphylococcal Infections</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072283" MajorTopicYN="N">A549 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001422" MajorTopicYN="N">Bacterial Adhesion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037521" MajorTopicYN="N">Virulence Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Staphylococcus aureus</Keyword><Keyword MajorTopicYN="N">adhesion</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337536</ArticleId><ArticleId IdType="pmc">PMC11431965</ArticleId><ArticleId IdType="doi">10.3390/ijms251810050</ArticleId><ArticleId IdType="pii">ijms251810050</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Joseph C., Togawa Y., Shindo N. Bacterial and Viral Infections Associated with Influenza. Influenza Other Respir. Viruses. 2013;7:105–113. doi: 10.1111/irv.12089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12089</ArticleId><ArticleId IdType="pmc">PMC5909385</ArticleId><ArticleId IdType="pubmed">24034494</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulcahy M.E., McLoughlin R.M. Staphylococcus aureus and Influenza A Virus: Partners in Coinfection. mBio. 2016;7:10-1128. doi: 10.1128/mBio.02068-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02068-16</ArticleId><ArticleId IdType="pmc">PMC5156308</ArticleId><ArticleId IdType="pubmed">27965455</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgogna T.R., Hisey B., Heitmann E., Obar J.J., Meissner N., Voyich J.M. Secondary Bacterial Pneumonia by Staphylococcus aureus Following Influenza a Infection Is SaeR/S Dependent. J. Infect. Dis. 2018;218:809–813. doi: 10.1093/infdis/jiy210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy210</ArticleId><ArticleId IdType="pmc">PMC6057542</ArticleId><ArticleId IdType="pubmed">29668950</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgene M.F., Botelho-Nevers E., Grattard F., Pillet S., Berthelot P., Pozzetto B., Verhoeven P.O. Staphylococcus aureus Colonization and Non-Influenza Respiratory Viruses: Interactions and Synergism Mechanisms. Virulence. 2018;9:1354–1363. doi: 10.1080/21505594.2018.1504561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2018.1504561</ArticleId><ArticleId IdType="pmc">PMC6177244</ArticleId><ArticleId IdType="pubmed">30058450</ArticleId></ArticleIdList></Reference><Reference><Citation>Cusumano J.A., Dupper A.C., Malik Y., Gavioli E.M., Banga J., Berbel Caban A., Nadkarni D., Obla A., Vasa C.V., Mazo D., et al. Staphylococcus aureus Bacteremia in Patients Infected with COVID-19: A Case Series. Open Forum Infect. Dis. 2020;7:ofaa518. doi: 10.1093/ofid/ofaa518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa518</ArticleId><ArticleId IdType="pmc">PMC7686656</ArticleId><ArticleId IdType="pubmed">33269299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreitmann L., Monard C., Dauwalder O., Simon M., Argaud L. Early Bacterial Co-Infection in ARDS Related to COVID-19. Intensive Care Med. 2020;46:1787–1789. doi: 10.1007/s00134-020-06165-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06165-5</ArticleId><ArticleId IdType="pmc">PMC7358293</ArticleId><ArticleId IdType="pubmed">32661615</ArticleId></ArticleIdList></Reference><Reference><Citation>Adalbert J.R., Varshney K., Tobin R., Pajaro R. Clinical Outcomes in Patients Co-Infected with COVID-19 and Staphylococcus Aureus: A Scoping Review. BMC Infect. Dis. 2021;21:985. doi: 10.1186/s12879-021-06616-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06616-4</ArticleId><ArticleId IdType="pmc">PMC8453255</ArticleId><ArticleId IdType="pubmed">34548027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluytmans J., van Belkum A., Verbrugh H. Nasal Carriage of Staphylococcus aureus: Epidemiology, Underlying Mechanisms, and Associated Risks. Clin. Microbiol. Rev. 1997;10:505–520. doi: 10.1128/CMR.10.3.505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.10.3.505</ArticleId><ArticleId IdType="pmc">PMC172932</ArticleId><ArticleId IdType="pubmed">9227864</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuter J., Hatcher V.B., Lowy F.D. Staphylococcus aureus Binding to Human Nasal Mucin. Infect. Immun. 1996;64:310–318. doi: 10.1128/iai.64.1.310-318.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.64.1.310-318.1996</ArticleId><ArticleId IdType="pmc">PMC173761</ArticleId><ArticleId IdType="pubmed">8557357</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Eiff C., Becker K., Machka K., Stammer H., Peters G. Nasal Carriage as a Source of Staphylococcus aureus Bacteremia. N. Engl. J. Med. 2001;344:11–16. doi: 10.1056/NEJM200101043440102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200101043440102</ArticleId><ArticleId IdType="pubmed">11136954</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowy Franklin D. Staphylococcus aureus Infections. N. Engl. J. Med. 1998;339:520–532. doi: 10.1056/NEJM199808203390806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199808203390806</ArticleId><ArticleId IdType="pubmed">9709046</ArticleId></ArticleIdList></Reference><Reference><Citation>van Belkum A., Melles D.C., Nouwen J., van Leeuwen W.B., van Wamel W., Vos M.C., Wertheim H.F.L., Verbrugh H.A. Co-Evolutionary Aspects of Human Colonisation and Infection by Staphylococcus aureus. Infect. Genet. Evol. 2009;9:32–47. doi: 10.1016/j.meegid.2008.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2008.09.012</ArticleId><ArticleId IdType="pubmed">19000784</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown S.P., Cornforth D.M., Mideo N. Evolution of Virulence in Opportunistic Pathogens: Generalism, Plasticity, and Control. Trends Microbiol. 2012;20:336–342. doi: 10.1016/j.tim.2012.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2012.04.005</ArticleId><ArticleId IdType="pmc">PMC3491314</ArticleId><ArticleId IdType="pubmed">22564248</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster T.J., Geoghegan J.A., Ganesh V.K., Höök M. Adhesion, Invasion and Evasion: The Many Functions of the Surface Proteins of Staphylococcus aureus. Nat. Rev. Microbiol. 2014;12:49–62. doi: 10.1038/nrmicro3161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3161</ArticleId><ArticleId IdType="pmc">PMC5708296</ArticleId><ArticleId IdType="pubmed">24336184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kintarak S., Whawell S.A., Speight P.M., Packer S., Nair S.P. Internalization of Staphylococcus aureus by Human Keratinocytes. Infect. Immun. 2004;72:5668–5675. doi: 10.1128/IAI.72.10.5668-5675.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.72.10.5668-5675.2004</ArticleId><ArticleId IdType="pmc">PMC517534</ArticleId><ArticleId IdType="pubmed">15385465</ArticleId></ArticleIdList></Reference><Reference><Citation>Speziale P., Pietrocola G. The Multivalent Role of Fibronectin-Binding Proteins A and B (FnBPA and FnBPB) of Staphylococcus aureus in Host Infections. Front. Microbiol. 2020;11:2054. doi: 10.3389/fmicb.2020.02054.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.02054</ArticleId><ArticleId IdType="pmc">PMC7480013</ArticleId><ArticleId IdType="pubmed">32983039</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock S.J., Moore C.E., Justice A., Kantzanou M., Story L., Mackie K., O’Neill G., Day N.P.J. Virulent Combinations of Adhesin and Toxin Genes in Natural Populations of Staphylococcus aureus. Infect. Immun. 2002;70:4987–4996. doi: 10.1128/IAI.70.9.4987-4996.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.70.9.4987-4996.2002</ArticleId><ArticleId IdType="pmc">PMC128268</ArticleId><ArticleId IdType="pubmed">12183545</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuchscherr L., Löffler B. Staphylococcus aureus Dynamically Adapts Global Regulators and Virulence Factor Expression in the Course from Acute to Chronic Infection. Curr. Genet. 2016;62:15–17. doi: 10.1007/s00294-015-0503-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00294-015-0503-0</ArticleId><ArticleId IdType="pubmed">26123224</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraunholz M., Sinha B. Intracellular Staphylococcus aureus: Live-in and Let Die. Front. Cell. Infect. Microbiol. 2012;2:43. doi: 10.3389/fcimb.2012.00043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2012.00043</ArticleId><ArticleId IdType="pmc">PMC3417557</ArticleId><ArticleId IdType="pubmed">22919634</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto M. Staphylococcus aureus Toxins. Curr. Opin. Microbiol. 2014;17:32–37. doi: 10.1016/j.mib.2013.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2013.11.004</ArticleId><ArticleId IdType="pmc">PMC3942668</ArticleId><ArticleId IdType="pubmed">24581690</ArticleId></ArticleIdList></Reference><Reference><Citation>Mempel M., Lina G., Hojka M., Schnopp C., Seidl H.-P., Schäfer T., Ring J., Vandenesch F., Abeck D. High Prevalence of Superantigens Associated with the Egc Locus in Staphylococcus aureus Isolates from Patients with Atopic Eczema. Eur. J. Clin. Microbiol. Infect. Dis. 2003;22:306–309. doi: 10.1007/s10096-003-0928-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-003-0928-0</ArticleId><ArticleId IdType="pubmed">12743832</ArticleId></ArticleIdList></Reference><Reference><Citation>Lina G., Piémont Y., Godail-Gamot F., Bes M., Peter M.-O., Gauduchon V., Vandenesch F., Etienne J. Involvement of Panton-Valentine Leukocidin—Producing Staphylococcus aureus in Primary Skin Infections and Pneumonia. Clin. Infect. Dis. 1999;29:1128–1132. doi: 10.1086/313461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/313461</ArticleId><ArticleId IdType="pubmed">10524952</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillet Y., Issartel B., Vanhems P., Fournet J.-C., Lina G., Bes M., Vandenesch F., Piémont Y., Brousse N., Floret D., et al. Association between Staphylococcus aureus Strains Carrying Gene for Panton-Valentine Leukocidin and Highly Lethal Necrotising Pneumonia in Young Immunocompetent Patients. Lancet. 2002;359:753–759. doi: 10.1016/S0140-6736(02)07877-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)07877-7</ArticleId><ArticleId IdType="pubmed">11888586</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick J.K., Yarwood J.M., Schlievert P.M. Toxic Shock Syndrome and Bacterial Superantigens: An Update. Annu. Rev. Microbiol. 2001;55:77–104. doi: 10.1146/annurev.micro.55.1.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.55.1.77</ArticleId><ArticleId IdType="pubmed">11544350</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuchscherr L., Medina E., Hussain M., Völker W., Heitmann V., Niemann S., Holzinger D., Roth J., Proctor R.A., Becker K., et al. Staphylococcus aureus Phenotype Switching: An Effective Bacterial Strategy to Escape Host Immune Response and Establish a Chronic Infection. EMBO Mol. Med. 2011;3:129–141. doi: 10.1002/emmm.201000115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201000115</ArticleId><ArticleId IdType="pmc">PMC3395110</ArticleId><ArticleId IdType="pubmed">21268281</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuchscherr L., Geraci J., Löffler B. Staphylococcus aureus Regulator Sigma B Is Important to Develop Chronic Infections in Hematogenous Murine Osteomyelitis Model. Pathogens. 2017;6:31. doi: 10.3390/pathogens6030031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens6030031</ArticleId><ArticleId IdType="pmc">PMC5617988</ArticleId><ArticleId IdType="pubmed">28714889</ArticleId></ArticleIdList></Reference><Reference><Citation>Alouf J.E., Müller-Alouf H. Staphylococcal and Streptococcal Superantigens: Molecular, Biological and Clinical Aspects. Int. J. Med. Microbiol. 2003;292:429–440. doi: 10.1078/1438-4221-00232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1078/1438-4221-00232</ArticleId><ArticleId IdType="pubmed">12635926</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarzembowski T., Piechowicz L., Bronk M., Pałubicka A., Naumiuk Ł. Changes in the Protein Profile in Staphylococcal Strains from Patients Infected with the SARS-CoV-2 Virus. Pol. J. Microbiol. 2023;72:93–99. doi: 10.33073/pjm-2023-001.</Citation><ArticleIdList><ArticleId IdType="doi">10.33073/pjm-2023-001</ArticleId><ArticleId IdType="pmc">PMC10280328</ArticleId><ArticleId IdType="pubmed">36803915</ArticleId></ArticleIdList></Reference><Reference><Citation>Piechowicz L., Garbacz K., Galiński J. Staphylococcus aureus of Phage Type 187 Isolated from People Occurred to Be a Genes Carrier of Eneterotoxin C and Toxic Shock Syndrome Toxin-1 (TSST-1) Int. J. Hyg. Environ. Health. 2008;211:273–282. doi: 10.1016/j.ijheh.2007.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijheh.2007.06.010</ArticleId><ArticleId IdType="pubmed">17997135</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbacz K., Piechowicz L., Mroczkowska A. Distribution of Toxin Genes among Different Spa Types and Phage Types of Animal Staphylococcus aureus. Arch. Microbiol. 2015;197:935–940. doi: 10.1007/s00203-015-1127-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00203-015-1127-y</ArticleId><ArticleId IdType="pmc">PMC4536260</ArticleId><ArticleId IdType="pubmed">26108193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaźmierczak N., Grygorcewicz B., Piechowicz L. Biofilm Formation and Prevalence of Biofilm-Related Genes among Clinical Strains of Multidrug-Resistant Staphylococcus aureus. Microb. Drug Resist. 2021;27:956–964. doi: 10.1089/mdr.2020.0399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/mdr.2020.0399</ArticleId><ArticleId IdType="pubmed">33656375</ArticleId></ArticleIdList></Reference><Reference><Citation>Krut O., Utermöhlen O., Schlossherr X., Krönke M. Strain-Specific Association of Cytotoxic Activity and Virulence of Clinical Staphylococcus aureus Isolates. Infect. Immun. 2003;71:2716–2723. doi: 10.1128/IAI.71.5.2716-2723.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.71.5.2716-2723.2003</ArticleId><ArticleId IdType="pmc">PMC153241</ArticleId><ArticleId IdType="pubmed">12704146</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Qatouseh L.F., Chinni S.V., Seggewiß J., Proctor R.A., Brosius J., Rozhdestvensky T.S., Peters G., von Eiff C., Becker K. Identification of Differentially Expressed Small Non-Protein-Coding RNAs in Staphylococcus aureus Displaying Both the Normal and the Small-Colony Variant Phenotype. J. Mol. Med. 2010;88:565–575. doi: 10.1007/s00109-010-0597-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-010-0597-2</ArticleId><ArticleId IdType="pubmed">20151104</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuchscherr L., Pöllath C., Siegmund A., Deinhardt-Emmer S., Hoerr V., Svensson C.-M., Thilo Figge M., Monecke S., Löffler B. Clinical S. Aureus Isolates Vary in Their Virulence to Promote Adaptation to the Host. Toxins. 2019;11:135. doi: 10.3390/toxins11030135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins11030135</ArticleId><ArticleId IdType="pmc">PMC6468552</ArticleId><ArticleId IdType="pubmed">30823631</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziewanowska K., Patti J.M., Deobald C.F., Bayles K.W., Trumble W.R., Bohach G.A. Fibronectin Binding Protein and Host Cell Tyrosine Kinase Are Required for Internalization of Staphylococcus aureus by Epithelial Cells. Infect. Immun. 1999;67:4673–4678. doi: 10.1128/IAI.67.9.4673-4678.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.67.9.4673-4678.1999</ArticleId><ArticleId IdType="pmc">PMC96793</ArticleId><ArticleId IdType="pubmed">10456915</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionin B., Hammamieh R., Shupp J.W., Das R., Pontzer C.H., Jett M. Staphylococcal Enterotoxin B Causes Differential Expression of Rnd3 and RhoA in Renal Proximal Tubule Epithelial Cells While Inducing Actin Stress Fiber Assembly and Apoptosis. Microb. Pathog. 2008;45:303–309. doi: 10.1016/j.micpath.2008.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2008.07.002</ArticleId><ArticleId IdType="pubmed">18721871</ArticleId></ArticleIdList></Reference><Reference><Citation>Arroyo D.S., Soria J.A., Gaviglio E.A., Garcia-Keller C., Cancela L.M., Rodriguez-Galan M.C., Wang J.M., Iribarren P. Toll-like Receptor 2 Ligands Promote Microglial Cell Death by Inducing Autophagy. FASEB J. 2013;27:299–312. doi: 10.1096/fj.12-214312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.12-214312</ArticleId><ArticleId IdType="pmc">PMC3528320</ArticleId><ArticleId IdType="pubmed">23073832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitur K., Wachtel S., Brown A., Wickersham M., Paulino F., Peñaloza H.F., Soong G., Bueno S., Parker D., Prince A. Necroptosis Promotes Staphylococcus aureus Clearance by Inhibiting Excessive Inflammatory Signaling. Cell Rep. 2016;16:2219–2230. doi: 10.1016/j.celrep.2016.07.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.07.039</ArticleId><ArticleId IdType="pmc">PMC5001919</ArticleId><ArticleId IdType="pubmed">27524612</ArticleId></ArticleIdList></Reference><Reference><Citation>Soe Y.M., Bedoui S., Stinear T.P., Hachani A. Intracellular Staphylococcus aureus and Host Cell Death Pathways. Cell. Microbiol. 2021;23:e13317. doi: 10.1111/cmi.13317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.13317</ArticleId><ArticleId IdType="pubmed">33550697</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira D., Borges A., Simões M. Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases. Toxins. 2018;10:252. doi: 10.3390/toxins10060252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins10060252</ArticleId><ArticleId IdType="pmc">PMC6024779</ArticleId><ArticleId IdType="pubmed">29921792</ArticleId></ArticleIdList></Reference><Reference><Citation>Que Y.-A., Haefliger J.-A., Piroth L., François P., Widmer E., Entenza J.M., Sinha B., Herrmann M., Francioli P., Vaudaux P., et al. Fibrinogen and Fibronectin Binding Cooperate for Valve Infection and Invasion in Staphylococcus aureus Experimental Endocarditis. J. Exp. Med. 2005;201:1627–1635. doi: 10.1084/jem.20050125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050125</ArticleId><ArticleId IdType="pmc">PMC2212930</ArticleId><ArticleId IdType="pubmed">15897276</ArticleId></ArticleIdList></Reference><Reference><Citation>Garzoni C., Kelley W.L. Staphylococcus aureus: New Evidence for Intracellular Persistence. Trends Microbiol. 2009;17:59–65. doi: 10.1016/j.tim.2008.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2008.11.005</ArticleId><ArticleId IdType="pubmed">19208480</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz-Linek U., Werner J.M., Pickford A.R., Gurusiddappa S., Kim J.H., Pilka E.S., Briggs J.A.G., Gough T.S., Höök M., Campbell I.D., et al. Pathogenic Bacteria Attach to Human Fibronectin through a Tandem β-Zipper. Nature. 2003;423:177–181. doi: 10.1038/nature01589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01589</ArticleId><ArticleId IdType="pubmed">12736686</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldovan A., Fraunholz M.J. In or out: Phagosomal Escape of Staphylococcus aureus. Cell. Microbiol. 2019;21:e12997. doi: 10.1111/cmi.12997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12997</ArticleId><ArticleId IdType="pubmed">30576050</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinka J., Hachmeister M., Geraci J., Sordelli D., Hansen U., Niemann S., Oetermann S., Peters G., Löffler B., Tuchscherr L. Staphylococcus aureus Isolates from Chronic Osteomyelitis Are Characterized by High Host Cell Invasion and Intracellular Adaptation, but Still Induce Inflammation. Int. J. Med. Microbiol. 2014;304:1038–1049. doi: 10.1016/j.ijmm.2014.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmm.2014.07.013</ArticleId><ArticleId IdType="pubmed">25129555</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens D.M., Taubenberger J.K., Fauci A.S. Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness. J. Infect. Dis. 2008;198:962–970. doi: 10.1086/591708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591708</ArticleId><ArticleId IdType="pmc">PMC2599911</ArticleId><ArticleId IdType="pubmed">18710327</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullers J.A. The Co-Pathogenesis of Influenza Viruses with Bacteria in the Lung. Nat. Rev. Microbiol. 2014;12:252–262. doi: 10.1038/nrmicro3231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3231</ArticleId><ArticleId IdType="pubmed">24590244</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay M.Z., Poh C.M., Rénia L., MacAry P.A., Ng L.F.P. The Trinity of COVID-19: Immunity, Inflammation and Intervention. Nat. Rev. Immunol. 2020;20:363–374. doi: 10.1038/s41577-020-0311-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzaei R., Goodarzi P., Asadi M., Soltani A., Aljanabi H.A.A., Jeda A.S., Dashtbin S., Jalalifar S., Mohammadzadeh R., Teimoori A., et al. Bacterial Co-Infections with SARS-CoV-2. IUBMB Life. 2020;72:2097–2111. doi: 10.1002/iub.2356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2356</ArticleId><ArticleId IdType="pmc">PMC7436231</ArticleId><ArticleId IdType="pubmed">32770825</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Vidal C., Sanjuan G., Moreno-García E., Puerta-Alcalde P., Garcia-Pouton N., Chumbita M., Fernandez-Pittol M., Pitart C., Inciarte A., Bodro M., et al. Incidence of Co-Infections and Superinfections in Hospitalized Patients with COVID-19: A Retrospective Cohort Study. Clin. Microbiol. Infect. 2021;27:83–88. doi: 10.1016/j.cmi.2020.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.041</ArticleId><ArticleId IdType="pmc">PMC7836762</ArticleId><ArticleId IdType="pubmed">32745596</ArticleId></ArticleIdList></Reference><Reference><Citation>Karami Z., Knoop B.T., Dofferhoff A.S.M., Blaauw M.J.T., Janssen N.A., van Apeldoorn M., Kerckhoffs A.P.M., van de Maat J.S., Hoogerwerf J.J., ten Oever J. Few Bacterial Co-Infections but Frequent Empiric Antibiotic Use in the Early Phase of Hospitalized Patients with COVID-19: Results from a Multicentre Retrospective Cohort Study in The Netherlands. Infect. Dis. 2021;53:102–110. doi: 10.1080/23744235.2020.1839672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2020.1839672</ArticleId><ArticleId IdType="pubmed">33103530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes S., Troise O., Donaldson H., Mughal N., Moore L.S.P. Bacterial and Fungal Coinfection among Hospitalized Patients with COVID-19: A Retrospective Cohort Study in a UK Secondary-Care Setting. Clin. Microbiol. Infect. 2020;26:1395–1399. doi: 10.1016/j.cmi.2020.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.06.025</ArticleId><ArticleId IdType="pmc">PMC7320692</ArticleId><ArticleId IdType="pubmed">32603803</ArticleId></ArticleIdList></Reference><Reference><Citation>Westblade L.F., Simon M.S., Satlin M.J. Bacterial Coinfections in Coronavirus Disease 2019. Trends Microbiol. 2021;29:930–941. doi: 10.1016/j.tim.2021.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2021.03.018</ArticleId><ArticleId IdType="pmc">PMC8026275</ArticleId><ArticleId IdType="pubmed">33934980</ArticleId></ArticleIdList></Reference><Reference><Citation>Deinhardt-Emmer S., Haupt K.F., Garcia-Moreno M., Geraci J., Forstner C., Pletz M., Ehrhardt C., Löffler B. Staphylococcus aureus Pneumonia: Preceding Influenza Infection Paves the Way for Low-Virulent Strains. Toxins. 2019;11:734. doi: 10.3390/toxins11120734.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins11120734</ArticleId><ArticleId IdType="pmc">PMC6950557</ArticleId><ArticleId IdType="pubmed">31861176</ArticleId></ArticleIdList></Reference><Reference><Citation>Łubowska N., Grygorcewicz B., Kosznik-Kwaśnicka K., Zauszkiewicz-Pawlak A., Węgrzyn A., Dołęgowska B., Piechowicz L. Characterization of the Three New Kayviruses and Their Lytic Activity Against Multidrug-Resistant Staphylococcus aureus. Microorganisms. 2019;7:471. doi: 10.3390/microorganisms7100471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms7100471</ArticleId><ArticleId IdType="pmc">PMC6843549</ArticleId><ArticleId IdType="pubmed">31635437</ArticleId></ArticleIdList></Reference><Reference><Citation>Piechowicz L., Garbacz K. Poultry-Like pA+ Biotype of Staphylococcus aureus CC346/084 Clone in Human Population. Curr. Microbiol. 2016;73:124–131. doi: 10.1007/s00284-016-1033-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-016-1033-9</ArticleId><ArticleId IdType="pmc">PMC4899485</ArticleId><ArticleId IdType="pubmed">27061586</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarzembowski T., Jóźwik A., Wiśniewska K., Witkowski J. Flow Cytometry Approach Study of Enterococcus faecalis Vancomycin Resistance by Detection of Vancomycin@FL Binding to the Bacterial Cells. Curr Microbiol. 2010;61:407–410. doi: 10.1007/s00284-010-9628-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-010-9628-z</ArticleId><ArticleId IdType="pubmed">20361190</ArticleId></ArticleIdList></Reference><Reference><Citation>Daca A., Gołębiewska J., Bronk M., Jarzembowski T. Changes of Urine Isolates of Escherichia coli and Klebsiella pneumoniae Biofilm Affect Monocytes’ Response. World J. Microbiol. Biotechnol. 2021;37:181. doi: 10.1007/s11274-021-03150-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11274-021-03150-y</ArticleId><ArticleId IdType="pmc">PMC8476471</ArticleId><ArticleId IdType="pubmed">34580787</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrotra M., Wang G., Johnson W.M. Multiplex PCR for Detection of Genes for Staphylococcus aureus Enterotoxins, Exfoliative Toxins, Toxic Shock Syndrome Toxin 1, and Methicillin Resistance. J. Clin. Microbiol. 2000;38:1032–1035. doi: 10.1128/JCM.38.3.1032-1035.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.38.3.1032-1035.2000</ArticleId><ArticleId IdType="pmc">PMC86330</ArticleId><ArticleId IdType="pubmed">10698991</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarzembowski T., Jóźwik A., Wiśniewska K., Witkowski J., Jarzembowski T., Jóźwik A., Wiśniewska K., Witkowski J. Antibiotic Resistant Bacteria—A Continuous Challenge in the New Millennium. IntechOpen; London, UK: 2012. Single Cell Level Survey on Heterogenic Glycopeptide and β-Lactams Resistance.</Citation></Reference><Reference><Citation>Peyrusson F., Varet H., Nguyen T.K., Legendre R., Sismeiro O., Coppée J.-Y., Wolz C., Tenson T., Van Bambeke F. Intracellular Staphylococcus aureus Persisters upon Antibiotic Exposure. Nat. Commun. 2020;11:2200. doi: 10.1038/s41467-020-15966-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15966-7</ArticleId><ArticleId IdType="pmc">PMC7198484</ArticleId><ArticleId IdType="pubmed">32366839</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanenkov V.V., Felici F., Menon A.G. Uptake and Intracellular Fate of Phage Display Vectors in Mammalian Cells. Biochim. Biophys. Acta Mol. Cell Res. 1999;1448:450–462. doi: 10.1016/S0167-4889(98)00162-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-4889(98)00162-1</ArticleId><ArticleId IdType="pubmed">9990297</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan J., Ramachandran A., Thanki A.M., Vukusic F.B.I., Barylski J., Clokie M.R.J. Bacteriophages Are More Virulent to Bacteria with Human Cells than They Are in Bacterial Culture; Insights from HT-29 Cells. Sci. Rep. 2018;8:5091. doi: 10.1038/s41598-018-23418-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23418-y</ArticleId><ArticleId IdType="pmc">PMC5865146</ArticleId><ArticleId IdType="pubmed">29572482</ArticleId></ArticleIdList></Reference><Reference><Citation>Repetto G., del Peso A., Zurita J.L. Neutral Red Uptake Assay for the Estimation of Cell Viability/Cytotoxicity. Nat. Protoc. 2008;3:1125–1131. doi: 10.1038/nprot.2008.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.75</ArticleId><ArticleId IdType="pubmed">18600217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosznik-Kwaśnicka K., Stasiłojć M., Stasiłojć G., Kaźmierczak N., Piechowicz L. The Influence of Bacteriophages on the Metabolic Condition of Human Fibroblasts in Light of the Safety of Phage Therapy in Staphylococcal Skin Infections. Int. J. Mol. Sci. 2023;24:5961. doi: 10.3390/ijms24065961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065961</ArticleId><ArticleId IdType="pmc">PMC10055722</ArticleId><ArticleId IdType="pubmed">36983034</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>